Restasis 0.05%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Restasis 0.05%, covering 2019-08-30 to 2019-08-30. Get the full timeline:
Most recent: Clinical Trial Update: Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease) [Phase 2]